ES2176343T3 - Composiciones sanadoras de tratamiento de heridas causadas por el acne que contienen un piruvano, un antioxidante y una mezcla de acidos grasos. - Google Patents

Composiciones sanadoras de tratamiento de heridas causadas por el acne que contienen un piruvano, un antioxidante y una mezcla de acidos grasos.

Info

Publication number
ES2176343T3
ES2176343T3 ES95937364T ES95937364T ES2176343T3 ES 2176343 T3 ES2176343 T3 ES 2176343T3 ES 95937364 T ES95937364 T ES 95937364T ES 95937364 T ES95937364 T ES 95937364T ES 2176343 T3 ES2176343 T3 ES 2176343T3
Authority
ES
Spain
Prior art keywords
treatment
acne
compositions
antioxidant
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95937364T
Other languages
English (en)
Inventor
Alain Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2176343T3 publication Critical patent/ES2176343T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A COMPOSICIONES PARA LA CICATRIZACION DE HERIDAS Y TRATAMIENTO DEL ACNE, UTILES PARA EL TRATAMIENTO DEL ACNE VULGAR. LAS COMPOSICIONES INCLUYEN UNA CANTIDAD EFECTIVA TERAPEUTICAMENTE DE TRETINOINA Y UNA COMPOSICION CICATRIZANTE DE HERIDAS. EN UNA VERSION LA COMPOSICION INCLUYE (A) PIRUVATO; (B) UN ANTIOXIDANTE; Y (C) UNA MEZCLA DE ACIDOS GRASOS SATURADOS E INSATURADOS. LAS COMPOSICIONES PARA LA CICATRIZACION DE HERIDAS Y PARA EL TRATAMIENTO DEL ACNE VULGAR PUEDEN UTILIZARSE EN UNA AMPLIA VARIEDAD DE PRODUCTOS FARMACEUTICOS. ESTA INVENCION TAMBIEN SE REFIERE A METODOS PARA PREPARAR Y UTILIZAR LAS COMPOSICIONES PARA LA CICATRIZACION DE HERIDAS Y TRATAMIENTO DEL ACNE Y LOS PRODUCTOS FARMACEUTICOS EN LOS QUE SE PUEDEN UTILIZAR ESTAS COMPOSICIONES TERAPEUTICAS. ESTA INVENCION TAMBIEN SE REFIERE A METODOS PARA EMPLEAR LAS COMPOSICIONES DE CICATRIZACION DE HERIDAS Y TRATAMIENTO DEL ACNE PARA TRATAR ARRUGAS.
ES95937364T 1994-11-16 1995-10-05 Composiciones sanadoras de tratamiento de heridas causadas por el acne que contienen un piruvano, un antioxidante y una mezcla de acidos grasos. Expired - Lifetime ES2176343T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34057994A 1994-11-16 1994-11-16
US08/446,988 US5646190A (en) 1991-03-01 1995-05-22 Acne treating-wound healing compositions and methods for preparing and using same

Publications (1)

Publication Number Publication Date
ES2176343T3 true ES2176343T3 (es) 2002-12-01

Family

ID=26992170

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95937364T Expired - Lifetime ES2176343T3 (es) 1994-11-16 1995-10-05 Composiciones sanadoras de tratamiento de heridas causadas por el acne que contienen un piruvano, un antioxidante y una mezcla de acidos grasos.

Country Status (11)

Country Link
US (1) US5646190A (es)
EP (1) EP0792163B1 (es)
JP (1) JPH10509451A (es)
AU (1) AU697404B2 (es)
CA (1) CA2204145A1 (es)
DE (1) DE69526742T2 (es)
DK (1) DK0792163T3 (es)
ES (1) ES2176343T3 (es)
MX (1) MX9703354A (es)
NZ (1) NZ295852A (es)
WO (1) WO1996014868A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US7438896B2 (en) * 1995-09-20 2008-10-21 N.V. Perricone Llc Method of skin care using lipoic and ascorbic acids
DE19724622A1 (de) * 1997-06-11 1998-12-17 Beiersdorf Ag Verwendung von cis-6-Hexadecensäure zur Behandlung von Psoriasis, Allergien und Autoimmunerkrankungen
US6365623B1 (en) * 1997-11-17 2002-04-02 Nicholas V. Perricone Treatment of acne using lipoic acid
US5980920A (en) * 1998-03-02 1999-11-09 Lindquist; Niels L. Antioxidant compositions
CA2332808C (en) 1998-05-15 2010-11-23 Showa Denko K.K. Compositions of ascorbic acid derivatives for treatment of skin diseases
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
US6541517B1 (en) 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
WO2002032392A1 (en) * 2000-10-12 2002-04-25 Kao Corporation Skin pore minimizers and skin elasticity improvers
WO2002043731A2 (en) 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US6743433B2 (en) 2001-07-06 2004-06-01 Nicholas V. Perricone Treatment of acne using alkanolamine compositions
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
US20030198616A1 (en) * 2002-04-23 2003-10-23 Combe Incorporated Moisturizing skin gel and method
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
CA2525465A1 (en) * 2003-05-16 2004-11-25 Lotus Pharmaceutical Co., Ltd. Topical composition for transdermal administration
US20060147507A1 (en) * 2005-01-04 2006-07-06 Marie Cammarata Hot flash treatment system
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
MX2007015949A (es) 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
US20080132568A1 (en) * 2006-11-09 2008-06-05 Thompson Todd A Compounds with anti-androgenic activity and the use thereof
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
CN102395269B (zh) * 2009-04-17 2013-11-20 香波玉石碱株式会社 抗病毒剂及清洗剂
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US8470880B2 (en) * 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
EP2857025A1 (en) * 2013-10-02 2015-04-08 Special Water Patents B.V. Wound treatment composition
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法
WO2018175334A1 (en) 2017-03-20 2018-09-27 Es Biosolutions, Inc. Compositions and methods for skin treatments
US20230220205A1 (en) * 2020-05-29 2023-07-13 Industrias Alen, S.A. De C.V. Wax-like formulations of natural-origin materials and its method of preparation
KR102488895B1 (ko) * 2020-07-30 2023-01-17 주식회사 엘지생활건강 소듐 피루베이트를 유효성분으로 하는 미백 화장료 조성물

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887702A (en) * 1973-08-30 1975-06-03 Mildred Baldwin Composition and method for treating fingernails and toenails
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US3984566A (en) * 1974-02-25 1976-10-05 Scott Eugene J Van Method of alleviating the symptoms of dandruff
US3988470A (en) * 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
JPS5132738A (ja) * 1974-09-13 1976-03-19 Mikio Nakanishi Kokagakusumotsugunohigaioboshisuru hoho
US4158057A (en) * 1975-03-28 1979-06-12 Stanko Ronald T Prevention of the accumulation of fatty deposits in the liver
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4197316A (en) * 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4170821A (en) * 1977-12-02 1979-10-16 Warner-Lambert Company Razor cartridges
US4284630A (en) * 1978-03-22 1981-08-18 Yu Ruey J Stabilized water-in-oil emulsions
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
JPS5783287A (en) * 1980-11-14 1982-05-25 Kyowa Hakko Kogyo Co Ltd Elimination of hydrogen peroxide
US4548937A (en) * 1981-04-01 1985-10-22 Montefiore Hospital Method for preventing body fat deposition in mammals
US4812479A (en) * 1981-04-01 1989-03-14 The Montefiore Hospital Society Of Western Pennsylvania, Inc. Method for preventing body fat deposition in mammals
US4351835A (en) * 1981-04-01 1982-09-28 Montefiore Hospital Method for preventing body fat deposition in mammals
US4415576A (en) * 1981-04-01 1983-11-15 Montefiore Hospital Method for preventing body fat deposition in mammals
US4645764A (en) * 1981-04-01 1987-02-24 Montefiore Hospital Method for preventing body fat deposition in animals
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell
US4454159A (en) * 1981-12-28 1984-06-12 Albert Musher Dermatological treatment preparations
DE3201511A1 (de) * 1982-01-20 1983-07-28 Henkel Kgaa Sebosuppressive kosmetische mittel, welche laengerkettige alkanole und antioxidantien enthalten
US4451482A (en) * 1982-04-22 1984-05-29 Shell Oil Company Method of preventing or ameliorating pyrethroid skin sensory stimulation
US4521375A (en) * 1982-11-23 1985-06-04 Coopervision, Inc. Sterilizing treatment with hydrogen peroxide and neutralization of residual amounts thereof
ATE151286T1 (de) * 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
US4663166A (en) * 1984-06-22 1987-05-05 Veech Richard L Electrolyte solutions and in vivo use thereof
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4935495A (en) * 1984-12-21 1990-06-19 Oncogen Monoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomas
US4696917A (en) * 1985-08-01 1987-09-29 Lindstrom Richard L Irrigation solution
CS262822B1 (en) * 1986-10-03 1989-04-14 Kovar Jan Synthetic medium for the cultivation of myelomic cells
DE3719097C1 (de) * 1987-06-06 1988-06-09 Fratzer Uwe Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E
US4847069A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
US4847072A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate
US4847071A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
TR22895A (tr) * 1988-05-02 1988-10-11 Permatik Celik Ve Plastik San Platform ve bashk kisimlarinin tamami yardimci tiras malzemesi katkisiyla ueretilen,sulu ortamda kaygan zemin olusturan,bir veya cok bicakh tiras ueniteleri
EP0345082A3 (en) * 1988-06-02 1990-04-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Enzyme formation suppressing agent
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
CA2018471A1 (en) * 1989-07-28 1991-01-28 Ian W. Kellaway Mucoadhesive hydrogels delivery system
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
PH31403A (en) * 1991-03-01 1998-10-29 Warner Lambert Co Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.
CA2123678A1 (en) * 1991-11-26 1993-06-10 Alain Martin Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
US5296307A (en) * 1992-05-08 1994-03-22 Electric Power Research Institute, Inc. Laminated paper polyolefin paper composite

Also Published As

Publication number Publication date
WO1996014868A1 (en) 1996-05-23
MX9703354A (es) 1998-02-28
DK0792163T3 (da) 2002-09-09
DE69526742T2 (de) 2002-11-21
EP0792163A1 (en) 1997-09-03
US5646190A (en) 1997-07-08
NZ295852A (en) 1998-08-26
AU697404B2 (en) 1998-10-08
JPH10509451A (ja) 1998-09-14
AU3949295A (en) 1996-06-06
DE69526742D1 (de) 2002-06-20
CA2204145A1 (en) 1996-05-23
EP0792163B1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
MX9703354A (es) Composiciones para tratar el acné y curar heridas que contienen un piruvato, un antioxidante y una mezcla de acidos grasos.
NZ308293A (en) Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids
NZ295303A (en) Sunscreen composition comprising a sunscreen agent, an anti-inflammatory agent and a composition for healing wounds
MX9606501A (es) Composiciones antifungosas y curativas para heridas y metodos para preparar y utilizar las mismas.
MX9606502A (es) Composiciones antiqueratoliticas y curativas para heridas y metodos para preparar y utilizar las mismas.
ES2171746T3 (es) Empleo de epinastina para el tratamiento de dolores.
ES2157422T3 (es) Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos.
NZ307055A (en) Immunostimulating-wound healing compositions and methods for preparing and using same
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
CU23226B7 (es) COMPOSICIONES ANALGéSICAS QUE COMPRENDEN COMPUESTOS ANTI-EPILéPTICOS Y ANTINFLAMATORIOS NO ESTEROIDEOS
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
ES2181993T3 (es) Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo.
ES2195175T3 (es) Preparacion farmaceutica que comprende acido eicosapentaenoico y/o acido estearidonico.
MX9200894A (es) Composiciones terapeuticas para proteger y resucitar las celulas de mamiferos y metodos para preparar y usar las mismas.
AR003220A1 (es) Derivados acilados de melatonina; composicion farmaceutica y cosmetica y el uso de los mismos para la preparacion de un medicamento.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
CO2021011652A2 (es) Ésteres de ácido graso como agentes anti-malassezia
ES2188656T3 (es) Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral.
CO5160247A1 (es) Composicion que cura heridas, antibacteriana bioadhesiva
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
ES2177594T3 (es) Combinaciones de sustancias y asoactivas con acidos grasos para prevenir la caida del cabello.
ES2194157T3 (es) Composiciones para el cuidado de la piel que contienen un retinoide.
ES2113222T3 (es) Utilizacion de derivados de acido benzoico para estimular el proceso de renovacion epidermica y tratar la piel.
PT994704E (pt) Utilizacao de analogos do gaba tal como a gabapentina no fabrico de um medicamento para o tratamento de doencas inflamatorias
AR001769A1 (es) Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación